SONM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DNA X Inc (SONM) is not a good buy at this moment for a beginner investor with a long-term strategy. The technical indicators are bearish, insiders are selling significantly, and there are no positive catalysts or strong trading signals to support an immediate investment. Additionally, while financials show some improvement in revenue and net income, the company is still operating at a loss, and gross margin has dropped significantly. Given the lack of positive sentiment and weak technicals, it is better to hold off on investing in SONM right now.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 24.036, not signaling oversold conditions. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading below key support levels, with S1 at 4.893 and S2 at 4.678, suggesting further downside risk.
Revenue increased by 7.94% YoY, and net income improved by 89.21% YoY in 2025/Q3.
Insiders are selling heavily, with a 610.08% increase in selling activity over the last month. Gross margin dropped significantly by -60.24% YoY. No recent news or positive sentiment from hedge funds or analysts.
In 2025/Q3, revenue increased to $16,214,000 (up 7.94% YoY), net income improved to -$4,753,000 (up 89.21% YoY), and EPS increased significantly by 831.97%. However, gross margin dropped sharply to 11.2%, down -60.24% YoY.
No recent analyst ratings or price target changes available.
